J Korean Med Assoc.  2010 Sep;53(9):736-738. 10.5124/jkma.2010.53.9.736.

Clinical research and patient protection

Affiliations
  • 1Committee for Ethics and Judicial Review, KMA, Korea.
  • 2Gachon University of Medicine and Science, Incheon, Korea. mooslee@gachon.ac.kr

Abstract

Clinical trials are the flower of clinical research. Recently such clinical trials occur increasingly on a global scale. Korea is also one of the countries newly involved in global clinical trials, with resulting scientific, economic, industrial, and ethical implications. The sweeping and meticulous precautions must be introduced to these global clinical trials promoting patient protection through the public, national and international surveillance. These many guidelines in clinical trials are based on the Declaration of Helsinki of the World Medical Association (WMA). Fortunately, we were proud to be able to host the WMA 2008 meeting in Seoul, where the sixth edition of this declaration was announced. Thus, KMA insists that all clinical trials in Korea maintain strict standards and that all our member physicians follow the Declaration of Helsinki and be observers.

Keyword

Clinical trials; Patient protection; Globalization; Helsinki Declaration

MeSH Terms

Flowers
Helsinki Declaration
Humans
Internationality
Korea
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr